Company Profiles

driven by the PitchBook Platform

BioMarcK Pharmaceuticals

BioMarcK Pharmaceuticals
2002 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$7.75M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of pharmaceutical drug platform created to treat pulmonary diseases. The company's pharmaceutical drug platform has over 100 peptides that inhibit the phosphorylation of the MARCKS protein, a well published primary mediator of an inflammatory cytokine release involved in respiratory disease and cancer progression, enabling patients with difficult to treat diseases to receive care.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Primary Office
2530 Meridian Parkway
Suite 300
Durham, NC 27713
United States

+1 (844) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BioMarcK Pharmaceuticals’s full profile, request a free trial.

BioMarcK Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC 07-Feb-2017 $7.75M 000.00 Completed Generating Revenue
13. Grant 01-Jun-2015 00.00 000.00 Completed Generating Revenue
12. Convertible Debt 09-Aug-2012 00000 000.00 Completed Generating Revenue
11. Grant 13-Sep-2011 00000 000.00 Completed Generating Revenue
10. Later Stage VC 28-Aug-2009 00.00 000.00 Completed Generating Revenue
9. Later Stage VC (Series C) 06-Apr-2009 00.00 0000 Completed Generating Revenue
8. Grant 02-Feb-2009 000 00.00 Completed Generating Revenue
7. Grant 01-Jan-2006 00.000 00.00 Completed Startup
6. Early Stage VC (Series B) 04-Feb-2005 000 00.00 Completed Startup
5. Grant 01-Jan-2004 00.000 00.000 Completed Startup
4. Angel (individual) 09-Oct-2003 00.000 00.000 Completed Startup
3. Early Stage VC (Series A) 10-Sep-2003 00.000 00.000 Completed Startup
2. Grant 01-Jan-2003 $100K Completed Startup
1. Accelerator/Incubator 01-Jan-2002 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

BioMarcK Pharmaceuticals Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
Cato BioVentures Corporate Venture Capital Minority 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
Springboard Enterprises Accelerator/Incubator Minority 000 0000 000000 0

BioMarcK Pharmaceuticals Executive Team (11)

Name Title Board
Seat
Contact
Info
Indu Parikh Ph.D Co-Founder & Chief Scientific Officer
Ted Murphy Ph.D Vice President, Research & Development
Brian Dickson Chief Executive Officer & Board Member
Mike Enright Chief Financial Officer
Thomas Roberg Co-Founder and Vice Chairman

6 Former Executives

You’re viewing 5 of 11 executives. Get the full list »

BioMarcK Pharmaceuticals Board Members (12)

Name Representing Role Since Contact
Info
Ashish Bhatia MD Self Board Member 000 0000
Brian Dickson BioMarcK Pharmaceuticals Chief Executive Officer & Board Member 000 0000
Craig Collard BioMarcK Pharmaceuticals Board Member 000 0000
Kennedy O'Herron Self Board Member 000 0000
Laura Calamos Nasir Ph.D Self Board Member 000 0000

4 Former Board Members

You’re viewing 5 of 12 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com